20 KiB
Executable File
20 KiB
Executable File
| 1 | Gene | Alteration | Oncogenic | Mutation_Effect | Citations |
|---|---|---|---|---|---|
| 2 | EP300 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 3 | EP300 | MLL-EP300 Fusion | Inconclusive | Inconclusive | 4 |
| 4 | EP300 | MOZ-EP300 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 5 | TCL1B | TRA-TCL1B Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 6 | PDGFRA | STRN-PDGFRA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 7 | PDGFRA | FIP1L1-PDGFRA Fusion | Oncogenic | Gain-of-function | 4 |
| 8 | PDGFRA | KDR-PDGFRA Fusion | Oncogenic | Gain-of-function | 4 |
| 9 | PDGFRA | BCR-PDGFRA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 10 | PDGFRA | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 11 | PDGFRA | ETV6-PDGFRA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 12 | PDGFRA | CDK5RAP2-PDGFRA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 13 | PDGFRA | KIF5B-PDGFRA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 14 | MAF | IGH-MAF Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 15 | NRG1 | SLC3A2-NRG1 fusion | Oncogenic | Gain-of-function | 4 |
| 16 | NRG1 | APP-NRG1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 17 | NRG1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 18 | NRG1 | ATP1B1-NRG1 fusion | Oncogenic | Gain-of-function | 4 |
| 19 | NRG1 | CD74-NRG1 fusion | Oncogenic | Gain-of-function | 4 |
| 20 | DDIT3 | FUS-DDIT3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 21 | DDIT3 | EWSR1-DDIT3 Fusion | Oncogenic | Gain-of-function | 4 |
| 22 | TLX3 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 23 | IL3 | IGH-IL3 Fusion | Oncogenic | Gain-of-function | 4 |
| 24 | EGFR | HMGA2-EGFR Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 25 | EGFR | EGFR-RAD51 Fusion | Oncogenic | Gain-of-function | 4 |
| 26 | EGFR | EGFR-SEPT14 Fusion | Oncogenic | Gain-of-function | 4 |
| 27 | TLX1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 28 | TCL1A | TRA-TCL1A Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 29 | CBFB | CBFB-MYH11 Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 30 | PDGFRB | TP53BP1-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 31 | PDGFRB | KANK1-PDGFRB Fusion | Oncogenic | Gain-of-function | 4 |
| 32 | PDGFRB | PRKG2-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 33 | PDGFRB | GIT2-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 34 | PDGFRB | PDE4DIP-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 35 | PDGFRB | BIN2-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 36 | PDGFRB | HIP1-PDGFRB Fusion | Oncogenic | Gain-of-function | 4 |
| 37 | PDGFRB | GPIAP1-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 38 | PDGFRB | WDR48-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 39 | PDGFRB | SPTBN1-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 40 | PDGFRB | RABEP1-PDGFRB Fusion | Oncogenic | Gain-of-function | 4 |
| 41 | PDGFRB | AGGF1-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 42 | PDGFRB | KIAA1509-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 43 | PDGFRB | CEP85L-PDGFRB Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 44 | PDGFRB | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 45 | PDGFRB | ATF7IP-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 46 | PDGFRB | EBF1-PDGFRB Fusion | Oncogenic | Gain-of-function | 4 |
| 47 | PDGFRB | GOLGA4-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 48 | PDGFRB | ETV6-PDGFRB Fusion | Oncogenic | Gain-of-function | 4 |
| 49 | PDGFRB | NIN-PDGFRB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 50 | MLLT3 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 51 | MYC | PVT1-MYC Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 52 | MYC | IGH-MYC Fusion | Oncogenic | Gain-of-function | 4 |
| 53 | MYC | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 54 | MYC | IGK-MYC Fusion | Oncogenic | Gain-of-function | 4 |
| 55 | MYC | IGL-MYC Fusion | Oncogenic | Gain-of-function | 4 |
| 56 | FGFR3 | IGH-FGFR3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 57 | FGFR3 | FGFR3-BAIAP2L1 Fusion | Oncogenic | Gain-of-function | 4 |
| 58 | FGFR3 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 59 | FGFR3 | FGFR3-TACC3 Fusion | Oncogenic | Gain-of-function | 4 |
| 60 | RAD51B | HMGA2-RAD51B Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 61 | ALK | ALK-GCC2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 62 | ALK | RANBP2-ALK Fusion | Oncogenic | Gain-of-function | 4 |
| 63 | ALK | NPM1-ALK Fusion | Oncogenic | Gain-of-function | 4 |
| 64 | ALK | ALK-ITGAV Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 65 | ALK | ALK-DYSF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 66 | ALK | CAD-ALK Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 67 | ALK | EML4-ALK Fusion | Oncogenic | Gain-of-function | 4 |
| 68 | ALK | STRN-ALK Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 69 | ALK | KIF5B-ALK Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 70 | ALK | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 71 | FGFR2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 72 | FGFR2 | FGFR2-ZMYM4 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 73 | FGFR2 | FGFR2-OPTN Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 74 | FGFR2 | KLK2-FGFR2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 75 | FGFR2 | FGFR2-MGEA5 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 76 | FGFR2 | FGFR2-TACC3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 77 | FGFR2 | FGFR2-PPHLN1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 78 | FGFR2 | FGFR2-KIAA1598 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 79 | FGFR2 | FGFR2-BICC1 Fusion | Oncogenic | Gain-of-function | 4 |
| 80 | FGFR2 | FGFR2-ATE1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 81 | FGFR2 | FGFR2-TACC2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 82 | FGFR2 | FGFR2-AHCYL1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 83 | FGFR2 | FGFR2-CIT Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 84 | FGFR2 | FGFR2-CCDC6 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 85 | FGFR2 | FGFR2-KIAA1967 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 86 | FGFR2 | FGFR2-FAM76A Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 87 | NOTCH1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 88 | NOTCH1 | MIR143-NOTCH1 Fusion | Inconclusive | Inconclusive | 4 |
| 89 | NOTCH1 | SEC16A-NOTCH1 Fusion | Oncogenic | Gain-of-function | 4 |
| 90 | FEV | EWSR1-FEV Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 91 | CIITA | Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 92 | CIITA | CIITA-BX648577 Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 93 | CIITA | NUBP1-CIITA Fusion | Likely Oncogenic | Loss-of-function | 4 |
| 94 | FGFR1 | ERLIN2-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 95 | FGFR1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 96 | FGFR1 | ZMYM2-FGFR1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 97 | FGFR1 | BAG4-FGFR1 Fusion | Likely Neutral | Likely Loss-of-function | 4 |
| 98 | FGFR1 | CEP110-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 99 | FGFR1 | CNTRL-FGFR1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 100 | FGFR1 | FGFR1OP-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 101 | FGFR1 | ZNF198-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 102 | FGFR1 | BCR-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 103 | FGFR1 | CUX1-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 104 | EPOR | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 105 | ABL2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 106 | KAT6A | KAT6A-TIF2 Fusion | Oncogenic | Gain-of-function | 4 |
| 107 | MECOM | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 108 | MECOM | GATA2-MECOM Fusion | Oncogenic | Gain-of-function | 4 |
| 109 | TRG | Fusion | Likely Oncogenic | Likely Gain-of-function | 2 |
| 110 | ETV5 | TMPRSS2-ETV5 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 111 | SS18 | SS18-SSX1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 112 | SS18 | SS18-SSX2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 113 | SQSTM1 | SQSTM1-NUP214 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 114 | ETV4 | TMPRSS2-ETV4 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 115 | ETV4 | EWSR1-ETV4 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 116 | FLT3 | ETV6-FLT3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 117 | VAV1 | VAV1-S100A7 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 118 | VAV1 | VAV1-MYO1F Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 119 | VAV1 | VAV1-THAP4 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 120 | ABL1 | NUP214-ABL1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 121 | ABL1 | BCR-ABL1 Fusion | Oncogenic | Gain-of-function | 4 |
| 122 | ABL1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 123 | BRAF | ARMC10-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 124 | BRAF | TRIM24-BRAF Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 125 | BRAF | FAM131B-BRAF Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 126 | BRAF | SND1-BRAF Fusion | Oncogenic | Gain-of-function | 4 |
| 127 | BRAF | ZKSCAN1-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 128 | BRAF | GTF2I-BRAF Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 129 | BRAF | AKAP9-BRAF Fusion | Oncogenic | Gain-of-function | 4 |
| 130 | BRAF | PCBP2-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 131 | BRAF | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 132 | BRAF | MKRN1-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 133 | BRAF | AGK-BRAF Fusion | Oncogenic | Gain-of-function | 4 |
| 134 | BRAF | KIAA1549-BRAF Fusion | Oncogenic | Gain-of-function | 4 |
| 135 | BRAF | CUL1-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 136 | BRAF | PAPSS1-BRAF Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 137 | BRAF | PPFIBP2-BRAF Fusion | Oncogenic | Gain-of-function | 4 |
| 138 | BRAF | AGAP3-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 139 | BRAF | ZNF767-BRAF Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 140 | TFE3 | SFPQ-TFE3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 141 | TFE3 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 142 | TFE3 | ASPSCR1-TFE3 Fusion | Oncogenic | Gain-of-function | 4 |
| 143 | TFE3 | PRCC-TFE3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 144 | TFE3 | YAP1-TFE3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 145 | MYBL1 | MYBL1¨CNFIB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 146 | BCORL1 | BCORL1-ELF4 Fusion | Likely Oncogenic | Likely Loss-of-function | 3 |
| 147 | TRD | Fusion | Likely Oncogenic | Likely Gain-of-function | 2 |
| 148 | CIC | CIC-DUX4 Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 149 | CIC | Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 150 | ERBB4 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 151 | ERBB4 | EZR-ERBB4 Fusion | Oncogenic | Gain-of-function | 4 |
| 152 | WT1 | EWSR1-WT1 Fusion | Oncogenic | Gain-of-function | 4 |
| 153 | NTRK3 | BTBD1-NTRK3 Fusion | Oncogenic | Gain-of-function | 4 |
| 154 | NTRK3 | EML4-NTRK3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 155 | NTRK3 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 156 | NTRK3 | ETV6-NTRK3 Fusion | Oncogenic | Gain-of-function | 4 |
| 157 | NTRK3 | KANK1-NTRK3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 158 | NTRK3 | UBE2R2-NTRK3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 159 | NTRK3 | HNRNPA2B1- NTRK3 Fusion | Inconclusive | Inconclusive | 4 |
| 160 | NR4A3 | EWSR1-NR4A3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 161 | BCL9 | MEF2D-BCL9 Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 162 | BCL9 | BCL9-IGH Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 163 | BCL9 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 164 | TRA | Fusion | Likely Oncogenic | Likely Gain-of-function | 2 |
| 165 | RBM15 | RBM15-MRTFA Fusion | Oncogenic | Gain-of-function | 4 |
| 166 | MYCL | RLF-MYCL Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 167 | BCL10 | IGH-BCL10 Fusion | Oncogenic | Gain-of-function | 4 |
| 168 | MAFB | IGH-MAFB Fusion | Oncogenic | Gain-of-function | 4 |
| 169 | NTRK2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 170 | NTRK2 | ETV6-NTRK2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 171 | NKX2-1 | TRA-NKX2-1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 172 | NKX2-1 | TRB-NKX2-1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 173 | NKX2-1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 174 | NKX2-1 | IGH-NKX2-1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 175 | TP63 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 176 | TRB | Fusion | Likely Oncogenic | Likely Gain-of-function | 2 |
| 177 | ETV1 | TMPRSS2-ETV1 Fusion | Oncogenic | Gain-of-function | 4 |
| 178 | ETV1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 179 | ETV1 | EWSR1-ETV1 Fusion | Oncogenic | Gain-of-function | 4 |
| 180 | ROS1 | FIG-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 181 | ROS1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 182 | ROS1 | TPM3-ROS1 Fusion | Oncogenic | Gain-of-function | 4 |
| 183 | ROS1 | CCDC6-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 184 | ROS1 | KDELR2-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 185 | ROS1 | CEP85L-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 186 | ROS1 | YWHAE-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 187 | ROS1 | GOPC-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 188 | ROS1 | CD74-ROS1 Fusion | Oncogenic | Gain-of-function | 4 |
| 189 | ROS1 | EZR-ROS1 Fusion | Oncogenic | Gain-of-function | 4 |
| 190 | ROS1 | LIMA1-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 191 | ROS1 | SDC4-ROS1 Fusion | Oncogenic | Gain-of-function | 4 |
| 192 | ROS1 | MSN-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 193 | ROS1 | LRIG3-ROS1 Fusion | Oncogenic | Gain-of-function | 4 |
| 194 | ROS1 | TFG-ROS1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 195 | ROS1 | SLC34A2-ROS1 Fusion | Oncogenic | Gain-of-function | 4 |
| 196 | NTRK1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 197 | NTRK1 | CD74-NTRK1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 198 | NTRK1 | TFG-NTRK1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 199 | NTRK1 | EPS15-NTRK1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 200 | NTRK1 | MPRIP-NTRK1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 201 | NTRK1 | TPR-NTRK1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 202 | NTRK1 | LMNA-NTRK1 Fusion | Oncogenic | Gain-of-function | 4 |
| 203 | NTRK1 | NFASC-NTRK1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 204 | RARA | BCOR-RARA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 205 | RARA | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 206 | RARA | PML-RARA Fusion | Oncogenic | Likely Gain-of-function | 4 |
| 207 | RARA | GTF2I-RARA Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 208 | BCL6 | IGH-BCL6 Fusion | Oncogenic | Gain-of-function | 4 |
| 209 | BCL6 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 210 | NUP98 | NUP98-NSD1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 211 | CCND3 | IGH-CCND3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 212 | TAL1 | SIL-TAL1 Fusion | Oncogenic | Gain-of-function | 4 |
| 213 | TAL1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 214 | PIK3CB | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 215 | PIK3CB | ACPP-PIK3CB Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 216 | RAF1 | ATG7-RAF1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 217 | RAF1 | GOLGA4-RAF1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 218 | RAF1 | SRGAP3-RAF1 Fusion | Oncogenic | Gain-of-function | 4 |
| 219 | RAF1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 220 | RAF1 | ESRP1-RAF1 Fusion | Oncogenic | Gain-of-function | 4 |
| 221 | RAF1 | QKI-RAF1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 222 | PDGFB | COL1A1-PDGFB Fusion | Oncogenic | Gain-of-function | 4 |
| 223 | TET1 | MLL-TET1 Fusion | Oncogenic | Gain-of-function | 4 |
| 224 | NUTM1 | BRD4-NUTM1 Fusion | Oncogenic | Gain-of-function | 4 |
| 225 | CCND1 | IGH-CCND1 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 226 | INSR | SLC12A2-INSR Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 227 | ESR1 | ESR1-SOX9 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 228 | ESR1 | ESR1-YAP1 Fusion | Oncogenic | Gain-of-function | 4 |
| 229 | ESR1 | ESR1-GYG1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 230 | ESR1 | ESR1-DAB2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 231 | ESR1 | ESR1-CCDC170 Fusion | Oncogenic | Gain-of-function | 4 |
| 232 | ESR1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 233 | CREBBP | KAT6A-CREBBP Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 234 | LMO2 | Fusion | Oncogenic | Gain-of-function | 4 |
| 235 | MALT1 | IGH-MALT1 Fusion | Inconclusive | Inconclusive | 4 |
| 236 | MALT1 | BIRC3-MALT1 Fusion | Oncogenic | Gain-of-function | 4 |
| 237 | ERG | EWSR1-ERG Fusion | Oncogenic | Gain-of-function | 4 |
| 238 | ERG | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 239 | ERG | FUS-ERG Fusion | Oncogenic | Gain-of-function | 4 |
| 240 | ERG | TMPRSS2-ERG Fusion | Oncogenic | Gain-of-function | 4 |
| 241 | GATA1 | MYB-GATA1 Fusion | Oncogenic | Gain-of-function | 4 |
| 242 | ATXN7 | RAD51C-ATXN7 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 243 | RET | RUFY1-RET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 244 | RET | EML4-RET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 245 | RET | MYH10-RET fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 246 | RET | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 247 | RET | KIF5B-RET Fusion | Oncogenic | Gain-of-function | 4 |
| 248 | RET | TRIM27-RET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 249 | RET | RET-SEPTIN9 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 250 | RET | SPECC1L-RET fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 251 | RET | NCOA4-RET Fusion | Oncogenic | Gain-of-function | 4 |
| 252 | RET | CCDC6-RET Fusion | Oncogenic | Gain-of-function | 4 |
| 253 | WIF1 | HMGA2-WIF1 Fusion | Inconclusive | Inconclusive | 4 |
| 254 | JAK2 | PCM1-JAK2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 255 | JAK2 | BCR-JAK2 Fusion | Oncogenic | Gain-of-function | 4 |
| 256 | JAK2 | TEL-JAK2 Fusion | Oncogenic | Gain-of-function | 4 |
| 257 | JAK2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 258 | JAK2 | ATF7IP-JAK2 Fusion | Oncogenic | Gain-of-function | 4 |
| 259 | JAK2 | PAX5-JAK2 Fusion | Oncogenic | Gain-of-function | 4 |
| 260 | MET | PTPRZ1-MET Fusion | Oncogenic | Gain-of-function | 4 |
| 261 | MET | HLA-DRB1-MET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 262 | MET | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 263 | MET | CCDC6-MET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 264 | MET | CD74-MET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 265 | MET | CLIP2-MET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 266 | MET | EPHB4-MET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 267 | MET | TFG-MET Fusion | Oncogenic | Gain-of-function | 4 |
| 268 | MET | KIF5B-MET Fusion | Oncogenic | Gain-of-function | 4 |
| 269 | MET | MET-DST Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 270 | MET | STARD3NL-MET Fusion | Oncogenic | Gain-of-function | 4 |
| 271 | MET | CD47-MET Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 272 | FUS | FUS-CREB3L2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 273 | FUS | FUS-CHOP Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 274 | FUS | FUS-ERG Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 275 | DUSP22 | Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 276 | YAP1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 277 | YAP1 | YAP1-MAMLD1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 278 | YAP1 | YAP1-FAM118B Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 279 | YAP1 | YAP1-SS18 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 280 | YAP1 | YAP1-TFE3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 281 | CRLF2 | P2RY8-CRLF2 Fusion | Oncogenic | Gain-of-function | 4 |
| 282 | CRLF2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 283 | CRLF2 | IGH-CRLF2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 284 | LTK | CLIP1-LTK fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 285 | BCL3 | IGH-BCL3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 286 | CREB1 | EWSR1-CREB1 Fusion | Inconclusive | Inconclusive | 4 |
| 287 | ATF1 | EWSR1-ATF1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 288 | BCL2 | IGH-BCL2 Fusion | Oncogenic | Gain-of-function | 4 |
| 289 | BCL2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 290 | FOXO1 | PAX7-FOXO1 Fusion | Inconclusive | Inconclusive | 4 |
| 291 | TYK2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 292 | PPARG | PAX8-PPARG Fusion | Oncogenic | Gain-of-function | 4 |
| 293 | MEF2D | MEF2D-SS18 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 294 | MEF2D | MEF2D-HNRNPUL1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 295 | MEF2D | MEF2D-DAZAP1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 296 | MEF2D | MEF2D-CSF1R Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 297 | MEF2D | MEF2D-FOXJ2 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 298 | PRKACA | DNAJB1-PRKACA Fusion | Oncogenic | Gain-of-function | 4 |
| 299 | IRF4 | DUSP22-IRF4 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 300 | IRF4 | IGH-IRF4 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 301 | IRF4 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 302 | TCF3 | TCF3-PBX1 Fusion | Oncogenic | Gain-of-function | 4 |
| 303 | TCF3 | TCF3-HLF Fusion | Oncogenic | Gain-of-function | 4 |
| 304 | SET | SET-NUP214 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 305 | BRD4 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 306 | FLI1 | EWSR1-FLI1 Fusion | Oncogenic | Gain-of-function | 4 |
| 307 | KMT2A | KMT2A-MLLT1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 308 | KMT2A | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 309 | KMT2A | KMT2A-MLLT3 Fusion | Oncogenic | Gain-of-function | 4 |
| 310 | RUNX1 | Fusion | Likely Oncogenic | Likely Loss-of-function | 4 |
| 311 | RUNX1 | ETV6-RUNX1 Fusion | Oncogenic | Likely Switch-of-function | 4 |
| 312 | RUNX1 | RUNX1-RUNX1T1 Fusion | Likely Oncogenic | Loss-of-function | 4 |
| 313 | RUNX1 | RUNX1-EVI1 Fusion | Likely Oncogenic | Loss-of-function | 4 |
| 314 | CCNB3 | BCOR-CCNB3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 315 | AKT1 | LAMTOR1-AKT1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 316 | HMGA1 | TBL1XR1-HMGA1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 317 | EWSR1 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 318 | FOXP1 | IGH-FOXP1 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 319 | AKT2 | BCAM-AKT2 Fusion | Likely Oncogenic | Gain-of-function | 4 |
| 320 | AKT2 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 321 | HMGA2 | HMGA2-LPP Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 322 | CSF1R | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 323 | CSF1R | RBM6-CSF1R Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 324 | DEK | DEK-NUP214 Fusion | Oncogenic | Gain-of-function | 4 |
| 325 | AKT3 | MAGI3-AKT3 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 326 | AKT3 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 327 | MLLT10 | KMT2A-MLLT10 Fusion | Oncogenic | Gain-of-function | 4 |
| 328 | MLLT10 | Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 329 | MLLT10 | PICALM-MLLT10 Fusion | Oncogenic | Gain-of-function | 4 |
| 330 | EP300 | EP300-MOZ Fusion | Likely Oncogenic | Gain-of-function | 3 |
| 331 | EP300 | EP300-MLL Fusion | Likely Oncogenic | Gain-of-function | 5 |
| 332 | FGFR1 | FGFR1-TACC1 Fusion | Oncogenic | Gain-of-function | 2 |
| 333 | FGFR1 | FGFR1OP1-FGFR1 Fusion | Likely Oncogenic | Gain-of-function | 5 |
| 334 | ALK | NPM-ALK Fusion | Oncogenic | Gain-of-function | 3 |
| 335 | NOTCH1 | SEC16A1-NOTCH1 Fusion | Oncogenic | Gain-of-function | 1 |
| 336 | NUP98 | NSD1-NUP98 Fusion | Likely Oncogenic | Likely Gain-of-function | 4 |
| 337 | GTF2I | Fusion | Likely Oncogenic | Likely Gain-of-function | 2 |
| 338 | NRG1 | SDC4-NRG1 Fusion | Likely Oncogenic | Likely Gain-of-function | |
| 339 | YY1 | EWSR1-YY1 Fusion | Inconclusive | Inconclusive | 1 |